In a major breakthrough, scientists led by Elena Deryugina at The Scripps Research Institute (TSRI) identified a specific protein, Latent TGFβ Binding Protein 3—LTBP3 for short—that kicks off a cellular chain reaction resulting in early-development tumors growing new blood vessels. These vessels then act like highways to spread cancer cells…...
The International Agency for Research on Cancer (IARC) and the World Cancer Research Fund (WCRF) have concluded that there is a causal association between diabetes and high BMI and several types of cancer. As the prevalence of these cancer risk factors increases, clinical and public health efforts should focus on identifying…...
The term nanomedicine, alluding to technologies with mechanisms and surface area characteristics sized in terms of billionths of a meter, has held promise for years, but breakthroughs specific to therapies have been limited. After five years of intense collaborative work by distinguished scientists from Arizona State University (ASU) and China’s…...
Respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice were recognized this evening as Giants of Cancer Care in an event at the Adler Planetarium in Chicago. Two of the 21 honorees are recent fellows of the National Foundation for Cancer…...
The National Foundation for Cancer Research’s (NFCR) annual marquee event was held in Washington, DC on Saturday evening, May 5th. The 2018 Szent-Györgyi Prize for Progress in Cancer Research ceremony and dinner occasioned much, including a gathering of NFCR principals and scientists, communication of the Foundation’s mandate, messages from the…...
FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations ROCKVILLE, MD – A trio of papers co-authored by…...
In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes, “how different molecular subtypes of glioma cells use different strategies…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
